Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma

NCT ID: NCT03036982

Last Updated: 2018-03-27

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 221 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-01-01
• Study Completion Date: 2017-12-31

Brief Summary

This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma Control Test (cACT) for mobile devices improves rate of completion and improves control of asthma in children and adolescents

Detailed Description

Asthma is the most prevalent chronic disease of childhood with an overall prevalence of 10%. While effective therapies exist to control symptoms and prevent exacerbations, many asthma patients experience significant morbidity including limitations on daily activities as well as asthma exacerbations that lead to missed school (and work for care givers) and necessitate emergency department visits and hospitalizations. Among children from lower socioeconomic statues and in black and Hispanic families, asthma incidence and severity are even greater. Reasons for this disparity included decreased access to effective asthma care, increased exposure to tobacco smoke and environmental allergens, and underutilization of controller medicines. These groups have significantly increased resource utilization due to emergency department visits and hospitalizations. Optimal care for asthma patients, especially those with at highest risk, will therefore require new strategies for evaluating ongoing control and providing direct feedback to patients.

We propose to transform the way asthma care is provided through the use of an innovative patient centered technology -Trivox Asthma - to improve quality of care and outcomes for asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to facilitate closer monitoring of patients with asthma through the existing web platform and a new mobile interface. This will allow asthma patients, their parents and school nurses to remotely input data on asthma control through smartphones and/or tablets. We will use the ACT+, an expansion of a validated measure currently utilized in both primary care and specialty clinics, to measure both asthma control and risk.

Effectiveness of this intervention will be measured by examining resource utilization and ongoing asthma control.

Conditions

Asthma

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Use of Mobile ACT

Will answer ACT (or cACT) and other asthma questions using mobile app

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Diagnosis of asthma
• Cared for at Boston Children's Hospital (Primary or secondary care)

Exclusion Criteria

• Age <4 or >21

• Minimum Eligible Age: 4 Years
• Maximum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Boston Children's Hospital

OTHER

Sponsor Role: lead

Responsible Party

Andrew MacGinnitie

Associate Clinical Director, Division of Immunology

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Andrew MacGinnitie, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Boston Children's Hosptial

Locations

Boston Childrens Hospital

Boston, Massachusetts, United States

Countries

United States

Other Identifiers

FP01013808

Identifier Type: -

Identifier Source: org_study_id